Sliding scale insulin
ApprovedSmall molecule
Sliding scale insulin is one of 97 small molecule programs targeting Gestational Diabetes. It is currently in Approved.
3
Indications
3
Total Trials
1
Active Trials
96
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
557 competitors in Chronic Obstructive Pulmonary Disease
#DrugCompanyPhaseTrials
1Sliding scale insulin
SSlotervaart Hospital
Approved
Veramyst
GSKPreclinical
Flovent
GSKPreclinical
Spiriva
Boehringer IngelheimPreclinical
Aclidinium Bromide
AstraZenecaPreclinical
Formoterol Fumarate
AstraZenecaPreclinical
Duragesic
CCephalon
Preclinical
Narcan
SScienture
Preclinical
Coumadin
AAbbott
Preclinical
Zoloft
VViatris Specialty LLC
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Chronic Obstructive Pulmonary Disease1 trial
Gestational Diabetes1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Sliding scale insulin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- SSlotervaart Hospital